1. Home
  2. CYTK vs FROG Comparison

CYTK vs FROG Comparison

Compare CYTK & FROG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cytokinetics Incorporated

CYTK

Cytokinetics Incorporated

HOLD

Current Price

$63.22

Market Cap

8.0B

Sector

Health Care

ML Signal

HOLD

Logo JFrog Ltd.

FROG

JFrog Ltd.

HOLD

Current Price

$55.86

Market Cap

7.9B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
CYTK
FROG
Founded
1997
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
8.0B
7.9B
IPO Year
2004
2020

Fundamental Metrics

Financial Performance
Metric
CYTK
FROG
Price
$63.22
$55.86
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
16
18
Target Price
$82.38
$66.72
AVG Volume (30 Days)
2.2M
1.7M
Earning Date
02-26-2026
02-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$87,211,000.00
$502,612,000.00
Revenue This Year
$339.72
$24.88
Revenue Next Year
$79.08
$16.59
P/E Ratio
N/A
N/A
Revenue Growth
2609.26
22.69
52 Week Low
$29.31
$27.00
52 Week High
$70.98
$70.43

Technical Indicators

Market Signals
Indicator
CYTK
FROG
Relative Strength Index (RSI) 50.00 37.91
Support Level $60.30 $54.27
Resistance Level $65.35 $58.78
Average True Range (ATR) 3.01 2.85
MACD -0.01 -0.78
Stochastic Oscillator 57.11 13.47

Price Performance

Historical Comparison
CYTK
FROG

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

About FROG JFrog Ltd.

JFrog Ltd provides an end-to-end, hybrid, universal DevOps Platform that powers and controls the software supply chain, enabling organizations to continuously and securely deliver software updates across any system. Its product portfolio includes JFrog Artifactory; JFrog Pipelines; JFrog Xray; JFrog Distribution; JFrog Artifactory Edge; JFrog Mission Control and JFrog Insight. Geographically, it derives a majority of revenue from Israel and also has its presence in United States, India and other regions.

Share on Social Networks: